CD1d Antikörper (AA 56-317)
Kurzübersicht für CD1d Antikörper (AA 56-317) (ABIN2800015)
Target
Alle CD1d (CD1D) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 56-317
-
Verwendungszweck
- CD1D antibody [N2C3], 0.91 mg/ml
-
Immunogen
- Recombinant fragment corresponding to a region within amino acids 56-317 of CD1D
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Tested Western blot
Application Notes
Suggested starting dilutions are as follows: WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.Sample (30 μg of whole cell lysate) A: Raji 10 % SDS PAGE CD1D antibody 107-10499 diluted at 1:1000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.91 mg/mL
-
Buffer
- 0.1M Tris, 0.1M Glycine, 10 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- CD1d (CD1D) (CD1d Molecule (CD1D))
-
Andere Bezeichnung
- CD1D
-
Molekulargewicht
- 38 kDa
-
Gen-ID
- 912
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-